Clinical Research Environment in India: Challenges and Proposed Solutions.

dc.contributor.author

Burt, Tal

dc.contributor.author

Sharma, Pooja

dc.contributor.author

Dhillon, Savita

dc.contributor.author

Manchanda, Mukul

dc.contributor.author

Mittal, Sanjay

dc.contributor.author

Trehan, Naresh

dc.coverage.spatial

United States

dc.date.accessioned

2015-03-14T10:25:14Z

dc.date.issued

2014-11-01

dc.description.abstract

India has compelling need and keen aspirations for indigenous clinical research. Notwithstanding this need and previously reported growth the expected expansion of Indian clinical research has not materialized. We reviewed the scientific literature, lay press reports, and ClinicalTrials.gov data for information and commentary on projections, progress, and impediments associated with clinical trials in India. We also propose targeted solutions to identified challenges. The Indian clinical trial sector grew by (+) 20.3% CAGR (compound annual growth rate) between 2005 and 2010 and contracted by (-) 14.6% CAGR between 2010 and 2013. Phase-1 trials grew by (+) 43.5% CAGR from 2005-2013, phase-2 trials grew by (+) 19.8% CAGR from 2005-2009 and contracted by (-) 12.6% CAGR from 2009-2013, and phase-3 trials grew by (+) 13.0% CAGR from 2005-2010 and contracted by (-) 28.8% CAGR from 2010-2013. This was associated with a slowing of the regulatory approval process, increased media coverage and activist engagement, and accelerated development of regulatory guidelines and recuperative initiatives. We propose the following as potential targets for restorative interventions: Regulatory overhaul (leadership and enforcement of regulations, resolution of ambiguity in regulations, staffing, training, guidelines, and ethical principles [e.g., compensation]).Education and training of research professionals, clinicians, and regulators.Public awareness and empowerment. After a peak in 2009-2010, the clinical research sector in India appears to be experiencing a contraction. There are indications of challenges in regulatory enforcement of guidelines; training of clinical research professionals; and awareness, participation, partnership, and the general image amongst the non-professional media and public. Preventative and corrective principles and interventions are outlined with the goal of realizing the clinical research potential in India.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/25590017

dc.identifier.uri

https://hdl.handle.net/10161/9503

dc.language

eng

dc.publisher

OMICS Publishing Group

dc.relation.ispartof

J Clin Res Bioeth

dc.relation.isversionof

10.4172/2155-9627.1000201

dc.title

Clinical Research Environment in India: Challenges and Proposed Solutions.

dc.type

Journal article

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/25590017

pubs.begin-page

1

pubs.end-page

8

pubs.issue

6

pubs.organisational-group

Duke

pubs.organisational-group

Faculty

pubs.publication-status

Published

pubs.volume

5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Burt et al India Clinical Reseach - J Clin Res Bioeth November 2014 - NIH Author Manuscript.pdf
Size:
428.39 KB
Format:
Adobe Portable Document Format
Description:
Published version